No Data
BTIG Downgrades Shattuck Labs(STTK.US) to Hold Rating, Cuts Target Price to $5
BTIG analyst Kaveri Pohlman downgrades $Shattuck Labs(STTK.US)$ to a hold rating, and adjusts the target price from $12 to $5.According to TipRanks data, the analyst has a success rate of 25.8% and a
Shattuck Labs Is Maintained at Buy by Needham
Shattuck Labs Is Maintained at Buy by Needham
Assessing Shattuck Labs: Insights From 6 Financial Analysts
During the last three months, 6 analysts shared their evaluations of Shattuck Labs (NASDAQ:STTK), revealing diverse outlooks from bullish to bearish.The following table summarizes their recent ratings
Needham Maintains Shattuck Labs(STTK.US) With Buy Rating, Cuts Target Price to $8
Needham analyst Gil Blum maintains $Shattuck Labs(STTK.US)$ with a buy rating, and adjusts the target price from $12 to $8.According to TipRanks data, the analyst has a success rate of 41.0% and a tot
Express News | Shattuck Labs Inc : Needham Cuts Target Price to $8 From $12
Shattuck Gains on Early-stage Data Update for Lead Asset in Blood Cancer
Shares of Shattuck Labs (NASDAQ:STTK) traded higher premarket Friday after the company announced updated interim data from an early-stage trial for its lead candidate SL-172154 in combination with chemotherapy azacitidine in blood cancer.